Ischemia-reperfusion: From cell biology to acute kidney injury

N Chatauret1, L Badet2, B Barrou2

  • 1INSERM, U1087, Ischémie-reperfusion en transplantation d'organe : mécanismes et innovations thérapeutiques, Poitiers ; université de Poitiers, faculté de Médecine et de Pharmacie, 86021 Poitiers, France; CHU de Poitiers, Laboratoire de biochimie, 86021 Poitiers, France.

Insights

Ischemia reperfusion injury in kidneys, common in transplants, causes acute kidney injury (AKI). This review details the cellular and molecular events during ischemia and reperfusion, impacting kidney function and transplant survival.

Area of Science:

  • Nephrology
  • Transplantation immunology
  • Cellular and molecular medicine

Background:

  • Ischemia reperfusion injury (IRI) is a critical complication in kidney transplantation and surgery.
  • IRI leads to acute kidney injury (AKI), impairing both short-term graft function and long-term transplant survival.
  • Chronic allograft nephropathy is a significant long-term consequence of IRI.

Purpose of the Study:

  • To review the cellular and molecular mechanisms of kidney IRI.
  • To describe the biological pathways activated during ischemia and reperfusion.
  • To highlight the differential susceptibility of kidney cells to ischemic injury.

Main Methods:

  • Literature review of cellular and molecular events in kidney IRI.
  • Analysis of biological pathways involved in ischemia and reperfusion phases.
  • Examination of distinct kidney cell responses (endothelial vs. epithelial) to ischemia.

Main Results:

  • Reperfusion following ischemia causes a surge in reactive oxygen species and depleted antioxidant defenses.
  • Kidney cells exhibit varying susceptibility to ischemic damage, with distinct endothelial and epithelial responses.
  • AKI resulting from IRI has profound implications for kidney allograft outcomes.

Conclusions:

  • Understanding the molecular basis of kidney IRI is crucial for improving transplant success.
  • Targeting cellular responses during ischemia and reperfusion may mitigate AKI and enhance graft survival.
  • Further research into differential cell susceptibility can inform therapeutic strategies for kidney protection.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.2K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
524
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
65
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.7K